DEM BioPharma
About:
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Website: https://dembiopharma.com/
Top Investors: Insight Partners, Alexandria Venture Investments, Emerson Collective, Pfizer Venture Investments, Alta Partners
Description:
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Total Funding Amount:
$70M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2022-01-01
Founders:
Christoph Westphal, David Donabedian, PhD, John Pribis
Number of Employees:
11-50
Last Funding Date:
2022-06-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai